Poniard Pharmaceuticals (PARD) Inactive 10-Q2007 Q1 Quarterly report

Filed: 10 May 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: accreted, accuracy, adhesion, advisory, Aeterna, AG, animal, Assessment, audit, Bayer, Biotech, capability, carryforward, catastrophic, Cheni, choose, civil, classified, Code, colon, column, compromised, contrary, criminal, Dainippon, death, disaster, discovery, disrupt, Dr, enacted, examination, experimentation, exported, external, FASB, filer, FIN, firm, focal, FOLFOX, foreseeable, formulation, framework, freely, frequency, Genzyme, GPC, heading, imported, imposition, improved, inception, incurrence, Interpretation, interrupted, interruption, IRB, IRC, judgment, Keryx, Kwok, lack, largest, light, Martell, Meabco, natural, nature, oral, organization, owner, oxaliplatin, Pharma, Pharmion, power, proceed, profile, prolong, ratio, reaching, recruit, refected, released, Reserved, resold, retrospectively, Ronald, scale, Schering, Secondary, Sheet, Shionogi, SK, solvency, SPA, SPEAR, structure, submit, substituted, Sumitomo, supplement, suspension, terrorist, thirty, Transave, uncertainty, underwriting, underwritten, variable, warning, Zeltia

Removed: accept, account, accounted, APBO, applied, arm, assuming, binomial, comparing, consistent, criteria, deteriorate, determined, developed, dispensing, dose, encounter, end, estimating, exceeded, fluorouracil, force, forma, fully, healthcare, ineffective, input, line, maintenance, methodology, minimal, modified, NX, offset, overcome, presenting, pro, rata, rationale, realized, representative, resistance, restructuring, select, sensitive, shipping, situation, solid, subjective, technique, topotecan, toxic, toxicity, transferable, transition, underlying, unsuccessful, unvested, unwilling, utilize, utilizing, vest, work

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PARD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of Quarterly Report

I, Gerald McMahon, Chief Executive Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350 that:

a. the Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

b. the information contained in the Report 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2007		By:		/s/ GERALD MCMAHON
				Gerald McMahon